产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 171452 | BGB 15025 ; BGB-15025 ; BGB15025 | 2766481-17-6 | ≧98.0% |  |
| BGB-15025 是一种有效的选择性 HPK1 抑制剂，在多种肿瘤模型中作为 | ||||
| 20419 | N-乙基-2-(4-甲酰基苯基)乙酰胺 | 2477812-42-1 | 98% Min. |  |
| 20403 | 497223-19-5 | 497223-19-5 | 98% Min. | phenyl]-1,2,3,4-tetrahydro-1-(2-methylpropyl)-1-Benzazocine-5-carboxylic_acid_497223-19-5.png) |
| 20391 | Benzeneacetic acid, 4-[[(2,4-dimethylbenzoyl)oxy]methyl]-, methyl ester | 2097334-15-9 | 98% Min. | oxy]methyl]-,_methyl_ester_2097334-15-9.png) |
| 20386 | 497223-19-5 | 497223-19-5 | 98% Min. | |
| G20381 | 1,10-BIS[4-AZA-1-AZONIABICYCLO[2.2.2]OCTAN-1-YL]DECANE DIBROMIDE | 94630-53-2 | 98% Min. |  |
| 20372 | 6-(苄氧基)-3,4-二氢萘-2(1H)-酮 | 885280-42-2 | 98% Min. |  |
| L20357 | BIBF0775 | 334951-90-5 | 98% Min. |  |
| BIBF0775 is an inhibitor of the transforming growth factor β receptor I (TGFβRI). X | ||||
| 6111905 | Blarcamesine HCl | 195615-84-0 | 98% Min. |  |
| Anavex2-73 is a muscarinic/σ1 ligand. ANAVEX2-73 (0.01-3.0 mg/kg i.p.) alleviated th | ||||
| 20271 | Bunamidine hydrochloride | 1055-55-6 | 98% Min. |  |
| Bunamidine is a anti-parasitic drug, which was approved by FDA for the treatment of t | ||||
| 20270 | BIT225 | 917909-71-8 | 98% Min. |  |
| BIT-225 is a NCp7 zinc finger inhibitor potentially for the treatment of HCV infectio | ||||
| 21234 | BI-3406 | 2230836-55-0 | 98% Min. |  |
| BI-3406 is Potent & Selective SOS1::KRAS Inhibitor (IC50=5 nM), which Opens a New | ||||
| 21224 | BI-187004 | 1303515-32-3 | ≧98.0% |  |
| BI-187004, also known as VTP-34072, is an 11β-hydroxysteroid dehydrogenase 1 inhibit | ||||
| 2021221 | Bafetinib | 887650-05-7 | 98% Min. |  |
| Bafetinib, also known as INNO-406 and NS187, is an orally bioavailable 2-phenylaminop | ||||
| 202112701 | BRD0705 | 2056261-41-5 | 98% Min. |  |
| BRD0705 is a potent, paralog selective and orally active GSK3α inhibitor. BRD0705 ca | ||||
| 20121701 | BLU-782 | 2141955-96-4 | 98% Min. |  |
| 20103006 | (2S,5R)-5-氨基-2-甲基哌啶-1-甲酸苄酯盐酸盐 | 1207853-23-3 | 98% Min. | -5-amino-2-methylpiperidine-1-carboxylatehydrochloride_1207853-23-3.png) |
| 2091907 | Benpyrine racemate | 1333714-43-4 | 98% Min. |  |
| (Rac)-Benpyrine is a racemate of Benpyrine. (Rac)-Benpyrine is a potent and orally ac | ||||
| 2091906 | BAY-2416964 | 2242464-44-2 | 98% Min. |  |
| BAY-2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist | ||||
| 2091902 | BI-894999 | 1660117-38-3 | 98% Min. |  |
| BI-894999 is a potent and selective BET inhibitor potentially useful for the Treatmen | ||||
| 2091206 | 4-溴-(2-丁氧基乙氧基)苯 | 39255-24-8 | 98% Min. | benzene_39255-24-8.png) |
| 2091203 | 4-(2-丁氧基乙氧基)苯基硼酸 | 279262-28-1 | 98% Min. | phenylboronic_acid_279262-28-1.png) |
| 2091201 | 6-BROMO-2-ETHYL-N,8-DIMETHYLIMIDAZO[1,2-A]PYRIDIN-3-AMINE | 1628264-07-2 | 98% Min. |  |
| 208192 | BCH001 | 384859-58-9 | ≧98.0% |  |
| BCH001是一种特异性PAPD5抑制剂，可在DC患者诱导的多能干细胞中恢 | ||||
| 2073102 | BMS-1166 | 1818314-88-3 | 98% Min. |  |
| BMS-1166是一种有效的PD-1 / PD-L1相互作用抑制剂，IC50为1.4 nM，可拮抗 | ||||
| 2071615 | BAY-1816032 | 1891087-61-8 | 98% Min. |  |
| BAY-1816032 is a potent and oral available BUB1 (budding uninhibited by benzimidazole | ||||
| 2071553 | BAY-2402234 | 2225819-06-5 | 98% Min. |  |
| BAY-2402234 is a potent and selective dihydroorotate dehydrogenase (DHODH) inhibitor | ||||
| 2071550 | BMVC-8C3O | 1301708-12-2 | 98% Min. |  |
| BMVC-8C3O is a DNA G-quadruplexe (G4) ligand which can induce topological conversion | ||||
| 2071532 | BAY-545 | 1699717-32-2 | 98% Min. |  |
| BAY-545 is a potent and selective antagonist of the A2B adenosine receptor. | ||||
| 52004 | Belnacasan | 273404-37-8 | 98% | _273404-37-8.png) |
| Belnacasan (VX-765) 是 VRT-043198 的口服生物活性前药，VRT-043198 是有效 | ||||